CN Stock MarketDetailed Quotes

603669 Lionco Pharmaceutical Group

Watchlist
  • 6.08
  • +0.04+0.66%
Market Closed Nov 15 15:00 CST
4.39BMarket Cap-43120P/E (TTM)

About Lionco Pharmaceutical Group Company

The company is an innovative enterprise group integrating pharmaceutical R&D, production, sales and medical services. Since its establishment in 2003, it has always adhered to the corporate tenet of “flexible intelligence, focus on health”. After more than ten years of entrepreneurial development, it was listed on the Shanghai Stock Exchange in May 2015. The company is mainly engaged in R&D, production and sales of chemical prescription drugs. The company's leading products cover the three major fields of parenteral nutritional drugs, anti-infective drugs, and digestive medicines. The company has successively won honors such as “China's Innovative Pharmaceutical Enterprises” and “China's Top 100 Comprehensive Pharmaceutical Research and Development Strength List”, and Lingkang Pharmaceutical's “An Omeprazole Sodium Hemihydrate and Preparation Method” patent won the China Patent Excellence Award.

Company Profile

Short Name-A灵康药业
Symbol-A603669
Company NameLionco Pharmaceutical Group Co.,Ltd.
Listing DateMay 28, 2015
Issue Price11.70
Shares Offered65.00M share(s)
FoundedDec 24, 2003
Listed ExchangeSH Stock Exchange
Legal Representativelingping tao
General Managerlingping tao
Secretaryguoping sui
Accounting FirmChina Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)
Securities Representativebaoyu liao
Legal CounselBeijing Zhonglun (Shenzhen) Law Firm
Employees55
Phone0893-7830999;0571-81103508
Office AddressNo. 20, National Highway No. 349 (Jiaba Township section), Naidong District, Shannan City, Tibet Autonomous Region
Zip Code856100
Registered AddressNo. 20, National Highway No. 349 (Jiaba Township section), Naidong District, Shannan City, Tibet Autonomous Region
Fax0893-7830888;0571-81103508
Emailir@lingkang.com.cn
Business License540000200018477
BusinessPharmaceutical wholesale; pharmaceutical production; drug contract production; pharmaceutical retail: pharmaceutical Internet information services; medical research and experimental development; technical services, technology development, technical consulting, technology exchange, technology transfer, technology promotion; housing leasing; non-residential real estate leasing; health products (pre-packaged) sales; food sales. (For projects requiring approval according to law, the activity can only be operated after approval by the relevant department)

Company Executives

  • Name
  • Position
  • Salary
  • lingping tao
  • Chairman, Directors, General Manager, Member of the Remuneration and Assessment Committee, Chairman of the Strategy Committee
  • 660.00K
  • liming liu
  • Directors, Deputy General Manager
  • --
  • hui zhang
  • Directors, Audit Committee Member
  • --
  • xiaogang tao
  • Directors, Deputy General Manager, Strategy Committee Member
  • 900.00K
  • qian he
  • Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
  • 120.00K
  • chao he
  • Independent Directors, Member of the Remuneration and Assessment Committee, Strategy Committee Member, Chairman of the Nomination Committee
  • 120.00K
  • ziqiang pan
  • Independent Directors, Nomination Committee Members, Chairman of the Audit Committee
  • 120.00K
  • guoping sui
  • Board Secretary, Deputy General Manager
  • --
  • baoyu liao
  • Securities Affairs Representative
  • --
  • xianjun fang
  • Chairman of the Supervisory Board, Auditors
  • --
  • yan chen
  • Shareholder Supervisors
  • 300.10K
  • shuangxi li
  • Deputy General Manager
  • 420.10K
  • hongsheng wang
  • Deputy General Manager
  • 400.10K
  • junke zhang
  • Chief Financial Officer
  • 850.00K
  • biyu zou
  • Employee Supervisors
  • 164.80K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data